
Browsing restrictions can be lifted for a fee.
The latest data point for Current Contract Liabilities of RXRX in Q4'25 stands at $151.6M USD, reflecting a modest quarter-over-quarter decline from $158.6M USD in Q3'25 and continuing a gradual downward trajectory in the latter part of the period. From Q1'23 to Q4'25, Current Contract Liabilities exhibited a consistent overall decline, starting at $114.9M USD and bottoming out at $61.4M USD in Q2'24, before a sharp rebound to $180.5M USD in Q4'24 driven by potential new contracts or recognitions. Subsequent quarters showed stabilization with minor fluctuations, averaging around $165M USD through Q3'25, underscoring a volatile yet predominantly contracting trend in deferred revenue obligations over the 12-quarter span.